An observational study in Gastrointestinal Transit Time, sponsored by KU Leuven. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by KU Leuven · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this study is to investigate the baseline of gastrointestinal transit time (GITT) and explore its relationship with other health indicators in 932 healthy adult volunteers.
The main questions it aims to answer are:
What are the population-level baseline values for GITT using the blue dye method? How is GITT associated with key physiological parameters including blood metabolic markers, life style, and stool characteristics?
Participants will:
Consume a standardized blue dye muffin after overnight fasting at the research center; Offer a finger prock blood samples for metabolic profiling; Offer a saliva sample for whole exome sequencing analysis; Collect stool samples for moisture measurement; Complete detailed questionnaires on diet, lifestyle, and bowel habits; Record the time of first blue stool appearance to determine GITT.
This explorative study is designed as a cross-sectional investigation aimed at establishing population-level reference values for gastrointestinal transit time (GITT). Adult participants from the general population will undergo GITT measurement using the blue-dye method. This muffin contains blue colorant that cannot be absorbed; after ingestion, it passes through the entire gastrointestinal tract and is eventually excreted in feces. Following a two-day lifestyle standardization period (including dietary and activity guidance) to minimize potential confounding effects on gastrointestinal motility, participants will attend a clinical visit where they will ingest a blue muffin. GITT will be determined by measuring both the time interval between ingestion of the blue muffin and the first appearance of blue-colored stool, and the duration from its first appearance to its complete disappearance.
The blue muffin method has been well-established in previous research for GITT assessment. Building upon the methodology developed by Berry et al., we will introduce stricter pre-test condition controls (includes dietary advice and lifestyle recommendations) and optimized the blue muffin formulation. These improvements allow for reliable measurement with a single muffin administration, which has been evaluated through KU Leuven Health Pass in a large sample size(S-70168).
To investigate potential determinants and correlates of GITT, we will collect biochemical parameters, fecal moisture, and resting metabolic rate. We will collect saliva samples for WGS to identify key genetic variants associated with GITT and use these findings to develop a genetic risk score. Additionally, participants will complete 24-h diet record and health questionnaires assessing bowel movement, physical activity habits, stress levels, sleep quality and hydration condition for subsequent correlation analyses.
KU Leuven is the lead sponsor of 373 studies on the registry; 65 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Healthy volunteers from the Flanders region who volunteered to participate in the research
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Child-Pugh class
A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Healthy adult participants without serious gastrointestinal diseases
Other: Diet
Participants will consume a regular muffin containing blue dye
Gastrointestinal transit time
Calculate the transit time by the recorded muffin consuming time, first blue stool appearance time and last blue stool appearance time
Time frame: From enrollment to the end of study at 2 weeks
Height (cm)
Measured using a height meter, in centimeters.
Time frame: baseline
Weight (kg)
Measuring using a scale, in kg.
Time frame: baseline
BMI
weight and height will be combined to report BMI in kg/m\^2
Time frame: baseline
Blood glucose (mmol/L)
Measure blood glucose by CardioChek Plus in mmol/L
Time frame: baseline
Fat mass (kg)
Using Bodystat quadscan 4000 to measure fat mass (kg)
Time frame: baseline
Lean body mass(kg)
Using Bodystat quadscan 4000 to measure lean body mass (kg)
Time frame: baseline
Fat percentage (%)
Using Bodystat quadscan 4000 to measure fat%
Time frame: baseline
Total cholesterol (mmol/L)
Measuring by Mission cholesterol Meter in mmol/L
Time frame: baseline
HDL-C (mmol/L)
Measuring by Mission cholesterol Meter in mmol/L
Time frame: baseline
LDL-C (mmol/L)
Measuring by Mission cholesterol Meter in mmol/L
Time frame: baseline
Triglyceride (mmol/L)
Measuring by Mission Cholesterol Meter in mmol/L
Time frame: baseline
Food record
Participants record their 24-h diets through smartphone application
Time frame: 2 days after study
Stool form
Stool form will be evaluated by Bristol Stool Form Scale, the score is from 1 to 7, with values closer to the middle indicating more ideal stool shape.
Time frame: baseline
Hydration status
Hydration status will be rated from 1 to 8 by Urine color chart, with higher numbers indicating that the body needs more water.
Time frame: baseline
Perceived level of stress
The10-item Perceived Stress will be used to measures an individual's perceived level of stress over the past month. The total score ranges from 0 to 40. A higher score indicates a greater perceived level of stress.
Time frame: baseline
Sleep quality
Pittsburgh Sleep Quality Index will be used to assess subjective sleep quality over the past month. The total score ranges from 0 to 21. A higher score indicates poorer sleep quality.
Time frame: baseline
Activity level
The Baecke Physical Activity Questionnaire will be used to assess daily habitual physical activity, with a particular focus on work-related and exercise-related activities. It does not produce a single total score, but rather scores on three dimensions, each typically ranging from 1 to 5. On each dimension, a higher score indicates a higher level of physical activity in that area. Therefore, for assessing activity levels, a higher score is generally better.
Time frame: baseline
Whole genome sequencing (WGS)
The genetic risk score will be calculated by summing the number of GITT-associated alleles carried by each participant, weighted by their estimated effect sizes. As the number and weights of the included variants will be determined during the analysis, the score does not have a predefined numerical range. The score will be standardized to a mean of 0 and a standard deviation of 1. A higher score will indicate a stronger genetic predisposition to the GITT phenotype of interest; it does not necessarily represent a better or worse health outcome.
Time frame: baseline
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Dec 2025 (actual). Primary completion is estimated for Dec 2026, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.